EXD-SP-2018 NSF膳食补充剂和功能食品项目cGMP审核条款.doc

想预览更多内容,点击预览全文

申明敬告:

本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己完全接受本站规则且自行承担所有风险,本站不退款、不进行额外附加服务;如果您已付费下载过本站文档,您可以点击这里二次下载

文档介绍

PAGE PAGE 10 / 83

EXD-SP-2018 NSF膳食补充剂和功能食品项目cGMP审核条款

NSF GMP 指导文件21CFR § 11/111 NSF/ANSI 173 第 8 章节

Prepared by NSF International 789 N. Dixboro Rd. Ann Arbor, MI 48105

Subpart B 111.10-111.14 Personnel 人员

Question 1 CFR 111.10

Procedures have been established that define work requirements for personnel to prevent microbial contamination from illness。

建立人员健康控制程序,以防由于人员患病而导致的微生物污染。

A written procedure shall exist and be current stating that personnel with medical conditions such as open lesions or infected wounds will be removed from the manufacturing process so as to prevent product adulteration during manufacturing or storage. The procedure shall state that such health conditions will be reported to supervision.

必须具备现行的书面程序,明确当员工在体表有伤口或患感染性创伤等身体状况时,将从生产过程中被调离,以避免在生产或仓储时发生产品掺杂。程序须规定员工如有上述

最近下载